TABLE 3.

Susceptibilities to fluoroquinolones of pneumococcal isolates from 12 Asian countries^a

Country	Levofloxacin				Moxifloxacin				Gatifloxacin				Ciprofloxacin
	MIC (mg/liter)		% I	% R	MIC (mg/liter)		% I	% R	MIC (mg/liter)		% I	% R	MIC (mg/liter)		% R
	90%	Range			90%	Range			90%	Range			90%	Range
Korea	2	0.25-2	0.0	0.0	0.25	0.06-0.5	0.0	0.0	0.5	0.12-1	0.0	0.0	2	0.25-4	6.5
China	1	0.12-2	0.0	0.0	0.25	0.004-1	0.0	0.0	0.5	<0.03-1	0.0	0.0	2	0.12->32	3.6
Thailand	1	0.5-2	0.0	0.0	0.25	0.03-0.5	0.0	0.0	0.5	<0.03-1	0.0	0.0	2	0.5-8	3.8
Taiwan	1	0.5-2	0.0	1.8	0.25	0.03-0.5	1.8	0.0	0.5	0.03-1	1.8	1.8	2	0.5-8	7
India	1	0.06-8	0.0	1.3	0.25	0.015-2	1.3	0.0	0.5	<0.03-8	0.0	1.4	2	0.12-16	4
Sri Lanka	1	0.5-2	0.0	0.0	0.25	0.06-0.5	0.0	0.0	0.5	0.12-1	0.0	0.0	2	0.5-4	9.5
Singapore	1	0.12-4	2.9	0.0	0.12	0.015-0.25	0.0	0.0	0.5	0.06-1	0.0	0.0	2	0.5-16	5.9
Malaysia	1	0.015-2	0.0	0.0	0.25	<0.002-1	0.0	0.0	0.5	0.06-1	0.0	0.0	2	<0.015-4	4.6
Vietnam	1	0.25-1	0.0	0.0	0.25	0.06-0.25	0.0	0.0	0.5	0.06-1	0.0	0.0	2	0.12->4	4.8
Philippines	1	0.5-2	0.0	0.0	0.25	0.03-0.5	0.0	0.0	0.5	0.06-1	0.0	0.0	2	0.5-4	9.1
Saudi Arabia	1	<0.004-2	0.0	0.0	0.25	<0.002-0.25	0.0	0.0	0.5	0.015-1	0.0	0.0	2	<0.015-4	2.6
Hong Kong	2	0.015-32	0.0	8.0	0.5	0.015-4	6.3	1.8	1	0.03-8	0.9	8.3	4	0.015-32	11.8
Total	1	<0.004-32	0.1	1.6	0.25	<0.002-4	1.3	0.3	0.5	0.03-8	0.3	1.6	2	0.008->32	6

^aMIC breakpoints for individual fluoroquinolones are as follows: for levofloxacin, I = 4 mg/liter and R = 8 mg/liter; for moxifloxacin, I = 2 mg/liter and R = 4 mg/liter; for gatifloxacin, I = 2 mg/liter and R ≥ 4 mg/liter; and for ciprofloxacin R ≥ 4 mg/liter.